// App-Quantinova.ai

: Description of the First Cases with ADAMTS13 Mutations in Hungary

Researchers

Presenter

  • Marienn Rti

Principal Investigators

  • Gyrgy Sinkovits

  • Orsolya Cseprekl

  • Dorottya Csuka

  • gnes Szilgyi

  • Zita Farkas

  • Zsolt Klucsik

  • Attila Szederjesi

  • Lszl Wgner

  • Gyrgy Reusz

  • Johanna A. Kremer Hovinga

  • Jnos Rig

  • Tamas Masszi

  • Zoltan Prohszka

Medical Centers

  • Department of Haematology and Stem Cell Transplantation, South‐Pest Central Hospital, National Institute for Haematology and Infectious Diseases, Budapest, Hungary

  • rd Department of Internal Medicine and Research Group of Immunology and Hematology, Semmelweis University, Budapest, Hungary

  • Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary

  • nd Department of Internal Medicine, Bács-Kiskun County Hospital, Kecskemét, HUN

  • Department of Pulmonology, Semmelweis University, Budapest, Hungary

  • Department of Clinical Pharmacology, University Bern, Berne, Switzerland

  • 2nd Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary

  • First Department of Internal Medicine, Semmelweis University, Budapest, Hungary

Locations

  • Hungary

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • End stage renal disease

  • Deep vein thrombosis

  • Venous thrombosis

  • Renal insufficiency

  • HELLP syndrome

  • Hypertension

  • Arrhythmia

  • Stroke

Biomarkers

  • N-Acylethanolamine acid amidase

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved